Stockscreener 앱 받기
90.74
2.12%
-1.97
시간 외 거래:
91.36
0.62
+0.68%
Abbott Laboratories 주식(ABT)의 최신 뉴스
Abbott Laboratories stock underperforms Tuesday when compared to competitors - MarketWatch
US criminal probe into Abbott infant-formula plant closed - Global Food Industry News
Trump Admin Stopped Criminal Charges Against Abbott Nutrition for Infant Formula Illnesses - Food Safety Magazine
Abbott Laboratories earnings calendar, shares in focus on the NYSE - AD HOC NEWS
Abbott Laboratories was investigated for poisoning babies. After a $500,000 donation, Trump let them off the hook. - More Perfect Union | Substack
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo! Finance Canada
Form 4 Abbott Laboratories For: 29 June By Investing.com - Investing.com Canada
Abbott (ABT) EVP Cushman disposes 560 shares for tax withholding, retains 38,013 - Stock Titan
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
Coca Cola Stock And 2 Defensive Picks For Steady Dividends - simplywall.st
MDL Sought for Abbott Spinal Cord Stimulator Lawsuits - AboutLawsuits.com
How Abbott's Largest Segment Is Preparing for the Next Growth Phase - TradingView
Abbott Laboratories dropped from Russell Top 50, shares hold above Tradegate level - AD HOC NEWS
Abbott Laboratories (ABT) Criminal Probe Closed by Justice Depar - GuruFocus
U.S. Justice Department Closes Criminal Probe into Abbott Laboratories - Intellectia AI
DOJ dropped Abbott baby formula criminal probe despite pile of evidence: WSJ (ABT:NYSE) - Seeking Alpha
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports - Reuters
Exclusive | The Baby Formula Probe Produced a Pile of Evidence. Then the DOJ Dropped the Case. - WSJ
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000 - The Motley Fool
Enterprise value to revenue forward of Abbott Laboratories – NYSE:ABT - TradingView
Abbott's Dual-Analyte Bet Positions It to Outpace Dexcom in the Expanding CGM Market - Kavout | AI
Abbott Laboratories (ABT) must face a Lawsuit over PediaSure, Statements about Children’s Growth - Insider Monkey
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
Abbott Laboratories (ABT) Stock After Recent Rebound Is There Still Value Left - Yahoo Finance
Abbott Laboratories' Q2 2026 earnings: What to expect - MSN
Abbott (ABT) Expands In Europe With Instinct CGM And Emerging Market Medicines - simplywall.st
Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now? - The Globe and Mail
Abbott Laboratories' Q2 2026 Earnings: What to Expect - Yahoo Finance
Abbott Laboratories sets Q2 earnings date, shares trade firmly on NYSE - Ad-hoc-news.de
Should you buy Abbott Labs stock hand over fist before July 16? - MSN
Abbott shares drop amid sector rotation but growth in diabetes and devices signals buying opportunity. - Pluang
Abbott Laboratories(NYSE: ABT) dropped from Russell Top 50 Index - marketscreener.com
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott Laboratories Stock (ABT) Moved Up by 3.12% on Jun 25: A Full Analysis - TradingKey
Buy, Hold, or Sell: Tech Compression Dragged Abbott Labs Under $91, but 1 Massive Diabetes Catalyst Makes It a Screaming Buy - AOL.com
Price to sales forward of Abbott Laboratories – NYSE:ABT - TradingView
Abbott Laboratories highlights diagnostics growth, shares sit in the S&P 500 health cohort - Ad-hoc-news.de
Price to sales forward of Abbott Laboratories – LSX:850103 - TradingView
$Abbott Laboratories (ABT.US)$ - Moomoo
Abbott to post Q2 results July 16, then host live webcast - Stock Titan
How An ALZpath Alzheimer’s Test Deal And Dividend Streak At Abbott (ABT) Has Changed Its Investment Story - simplywall.st
How Does Wall Street View Abbott Laboratories (ABT)’s Outlook? - Insider Monkey
ALZpath and Abbott Partner to Develop New Blood Test for Alzheimer’s Disease - Clinical Lab Products
Got $2,500? 1 Unstoppable Dividend Aristocrat With an Ironclad Moat to Buy - 24/7 Wall St.
Abbott partners with ALZpath on Alzheimer’s blood test - grafa.com
MiniMed Launches Abbott's Instinct Sensors Across European Markets - Yahoo Finance Singapore
ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test - Reuters
Abbott (ABT) Partners with ALZpath for Innovative Alzheimer's Di - GuruFocus
Dividend Stocks That Could Hold Up Better If Rates Stay Higher For Longer - simplywall.st
ALZpath licenses Alzheimer’s antibody to Abbott for diagnostic test - Investing.com
ALZpath licenses Alzheimer’s antibody to Abbott for diagnostic test By Investing.com - Investing.com Canada
How Are Emerging Markets Supporting Abbott's EPD Momentum? - Yahoo Finance
ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer's Disease Testing - Yahoo Finance
Abbott Laboratories midweek operations focus, NYSE healthcare stock steady on medical devices and di - Ad-hoc-news.de
Whistleblower alleges Abbott bribed Hawaiʻi provider - Medical Buyer
Abbott Laboratories (ABT) Stock Up 3.1% and Still Undervalued -- GF Score: 80/100 - GuruFocus
Missouri appeals court won't send Abbott's appeal of $495 million preterm baby formula verdict to higher court - Reuters
Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Abbott (ABT) Launches New Diabetes Management Systems in Europe - GuruFocus
Abbott Laboratories (NYSE:ABT): Is Market Too Harsh? - Kalkine Media
Abbott Laboratories Employees Credit Union Data Breach Settlement - Claim Depot
Ultrahuman teams up with Abbott Lingo to fix isolated glucose tracking - Wareable
4.74%
자본화:
|
볼륨(24시간):